Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs and collagen for stress urinary incontinence
NCT04446884Phase 2Completed
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose-derived mesenchymal stromal cells in stress urinary incontinence (SUI). Primary endpoints: Number of cured patients at 3 months and Number of patients with treatment-related adverse events at 4 weeks. Started Mar 2018; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT04446884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446884.